Altered Nrf2 signaling mediates hypoglycemia-induced blood-brain barrier endothelial dysfunction in vitro

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Sajja, Ravi K ^a   Green, Kayla N ^b   Cucullo, Luca ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b TEXAS CHRISTIAN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KELCH LIKE ECH ASSOCIATED PROTEIN 1; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NRF2; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; CADHERIN; CLAUDIN 5; LEUKOCYTE ANTIGEN; LEUPEPTIN; MESSENGER RNA; NQO1 PROTEIN, HUMAN; NUCLEAR PROTEIN; PROTEIN ZO1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SEVEN IN ABSENTIA PROTEINS; UBIQUITIN PROTEIN LIGASE; VASCULAR ENDOTHELIAL CADHERIN;

ANALYSIS OF VARIANCE; ARTICLE; BLOOD BRAIN BARRIER; CELL METABOLISM; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FEMALE; GENE; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOGLYCEMIA; IMMUNOREACTIVITY; IN VITRO STUDY; MEMBRANE PERMEABILITY; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHEAR STRESS; SIAH2 GENE; SIGNAL TRANSDUCTION; ANTAGONISTS AND INHIBITORS; CELL LINE; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; PATHOLOGY; PERMEABILITY; RNA INTERFERENCE; UPREGULATION;

ANTIGENS, CD; BLOOD-BRAIN BARRIER; CADHERINS; CELL LINE; CLAUDIN-5; DOWN-REGULATION; ENDOTHELIAL CELLS; FEMALE; HUMANS; HYPOGLYCEMIA; LEUPEPTINS; NAD(P)H DEHYDROGENASE (QUINONE); NF-E2-RELATED FACTOR 2; NUCLEAR PROTEINS; PERMEABILITY; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; UBIQUITIN-PROTEIN LIGASES; UP-REGULATION; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84926665031     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122358     Document Type: Article

References (51)

1. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010; 107: 1058-1070. doi: 10.1161/CIRCRESAHA.110.223545 PMID: 21030723
2. Horani MH, Mooradian AD. Effect of diabetes on the blood brain barrier. Curr Pharm Des. 2003; 9: 833-840. PMID: 12678883
3. Wright RJ, Frier BM. Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab Res Rev. 2008; 24: 353-363. doi: 10.1002/dmrr.865 PMID: 18461635
4. Cryer PE. Hypoglycemia, functional brain failure, and brain death. J Clin Invest. 2007; 117: 868-870. PMID: 17404614
5. Singh P, Jain A, Kaur G. Impact of hypoglycemia and diabetes on CNS: correlation of mitochondrial oxidative stress with DNA damage. Mol Cell Biochem. 2004; 260: 153-159. PMID: 15228097
6. Suh SW, Hamby AM, Gum ET, Shin BS, Won SJ, Sheline CT, et al. Sequential release of nitric oxide, zinc, and superoxide in hypoglycemic neuronal death. J Cereb Blood Flow Metab. 2008; 28: 1697-1706. doi: 10.1038/jcbfm.2008.61 PMID: 18545258
7. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis. 2010; 37: 13-25. doi: 10.1016/j.nbd.2009.07.030 PMID: 19664713
8. Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005; 57: 173-185. PMID: 15914466
9. Palmiotti CA, Prasad S, Naik P, Abul KM, Sajja RK, Achyuta AH, et al. In Vitro Cerebrovascular Modeling in the 21st Century: Current and Prospective Technologies. Pharm Res 31:3229-3250. doi: 10.1007/s11095-014-1464-6 PMID: 25098812
10. Sajja RK, Prasad S, Cucullo L. Impact of altered glycaemia on blood-brain barrier endothelium: an in vitro study using the hCMEC/D3 cell line. Fluids Barriers CNS. 2014; 11: 8. doi: 10.1186/2045-8118-11-8 PMID: 24708805
11. Ceriello A, Novials A, Ortega E, Canivell S, La SL, Pujadas G, et al. Glucagon-like peptide 1 reduces endothelial dysfunction, inflammation, and oxidative stress induced by both hyperglycemia and hypoglycemia in type 1 diabetes. Diabetes Care 2013; 6: 2346-2350.
12. Gogitidze JN, Hedrington MS, Briscoe VJ, Tate DB, Ertl AC, Davis SN. Effects of acute hypoglycemia on inflammatory and pro-atherothrombotic biomarkers in individuals with type 1 diabetes and healthy individuals. Diabetes Care 2010; 3: 1529-1535.
13. Wang J, Alexanian A, Ying R, Kizhakekuttu TJ, Dharmashankar K, Vasquez-Vivar J, et al. Acute exposure to low glucose rapidly induces endothelial dysfunction and mitochondrial oxidative stress: role for AMP kinase. Arterioscler Thromb Vasc Biol. 2012; 32: 712-720. doi: 10.1161/ATVBAHA.111.227389 PMID: 22207730
14. Kemeny SF, Figueroa DS, Clyne AM. Hypo- and hyperglycemia impair endothelial cell actin alignment and nitric oxide synthase activation in response to shear stress. PLoS One 2013; 8: e66176. doi: 10.1371/journal.pone.0066176 PMID: 23776627
15. Alfieri A, Srivastava S, Siow RC, Modo M, Fraser PA, Mann GE. Targeting the Nrf2-Keap1 antioxidant defence pathway for neurovascular protection in stroke. J Physiol. 2011; 589: 4125-4136. doi: 10.1113/jphysiol.2011.210294 PMID: 21646410
16. Calkins MJ, Johnson DA, Townsend JA, Vargas MR, Dowell JA, Williamson TP, et al. The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease. Antioxid Redox Signal. 2013; 11: 497-508.
17. Hayes JD, Dinkova-Kostova AT. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem Sci. 2014; 39: 199-218. doi: 10.1016/j.tibs.2014.02.002 PMID: 24647116
18. Holmstrom KM, Baird L, Zhang Y, Hargreaves I, Chalasani A, Land JM, et al. Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respiration. Biol Open. 2013; 2: 761-770. doi: 10.1242/bio.20134853 PMID: 23951401
19. Lee JM, Shih AY, Murphy TH, Johnson JA. NF-E2-related factor-2 mediates neuroprotection against mitochondrial complex I inhibitors and increased concentrations of intracellular calcium in primary cortical neurons. J Biol Chem. 2003; 278: 37948-37956. PMID: 12842875
20. Li T, Wang H, Ding Y, Zhou M, Zhou X, Zhang X, et al. Genetic elimination of Nrf2 aggravates secondary complications except for vasospasm after experimental subarachnoid hemorrhage in mice. Brain Res. 2014; 1558: 90-99. doi: 10.1016/j.brainres.2014.02.036 PMID: 24576487
21. Mitsuishi Y, Taguchi K, Kawatani Y, Shibata T, Nukiwa T, Aburatani H, et al. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell. 2012; 22: 66-79. doi: 10.1016/j.ccr.2012.05.016 PMID: 22789539
22. Benardais K, Pul R, Singh V, Skripuletz T, Lee DH, Linker RA, et al. Effects of fumaric acid esters on blood-brain barrier tight junction proteins. Neurosci Lett. 2013; 555: 165-170. doi: 10.1016/j.neulet.2013.09.038 PMID: 24076006
23. Wang X, Campos CR, Peart JC, Smith LK, Boni JL, Cannon RE, et al. Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood-brain and blood-spinal cord barriers. J Neurosci. 2014; 4: 8585-8593.
24. Zhao J, Moore AN, Redell JB, Dash PK. Enhancing expression of Nrf2-driven genes protects the blood brain barrier after brain injury. J Neurosci. 2007; 27: 10240-10248. PMID: 17881530
25. Alfieri A, Srivastava S, Siow RC, Cash D, Modo M, Duchen MR, et al. Sulforaphane preconditioning of the Nrf2/HO-1 defense pathway protects the cerebral vasculature against blood-brain barrier disruption and neurological deficits in stroke. Free Radic Biol Med. 2013; 65: 1012-1022. doi: 10.1016/j.freeradbiomed.2013.08.190 PMID: 24017972
26. Crunkhorn S. Deal watch: Abbott boosts investment in NRF2 activators for reducing oxidative stress. Nat Rev Drug Discov. 2012; 11: 96. doi: 10.1038/nrd3655 PMID: 22293557
27. Baba K, Morimoto H, Imaoka S. Seven in absentia homolog 2 (Siah2) protein is a regulator of NF-E2-related factor 2 (Nrf2). J Biol Chem. 2013; 288: 18393-18405. doi: 10.1074/jbc.M112.438762 PMID: 23645672
28. Nguyen T, Sherratt PJ, Huang HC, Yang CS, Pickett CB. Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome. J Biol Chem. 2003; 278: 4536-4541. PMID: 12446695
29. Chapple SJ, Siow RC, Mann GE. Crosstalk between Nrf2 and the proteasome: therapeutic potential of Nrf2 inducers in vascular disease and aging. Int J Biochem Cell Biol. 2012; 44: 1315-1320. doi: 10.1016/j.biocel.2012.04.021 PMID: 22575091
30. Weksler BB, Subileau EA, Perriere N, Charneau P, Holloway K, Leveque M, et al. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J. 2005; 19: 1872-1874. PMID: 16141364
31. Lincoln KM, Gonzalez P, Richardson TE, Julovich DA, Saunders R, Simpkins JW, et al. A potent antioxidant small molecule aimed at targeting metal-based oxidative stress in neurodegenerative disorders. Chem Commun (Camb). 2013; 49: 2712-2714. doi: 10.1039/c2cc36808k PMID: 23437435
32. Artus C, Glacial F, Ganeshamoorthy K, Ziegler N, Godet M, Guilbert T, et al. The Wnt/planar cell polarity signaling pathway contributes to the integrity of tight junctions in brain endothelial cells. J Cereb Blood Flow Metab. 2014; 34: 433-440. doi: 10.1038/jcbfm.2013.213 PMID: 24346691
33. Ohtsuki S, Ikeda C, Uchida Y, Sakamoto Y, Miller F, Glacial F, et al. Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model. Mol Pharm. 2013; 10: 289-296. doi: 10.1021/mp3004308 PMID: 23137377
34. Toth AE, Walter FR, Bocsik A, Santha P, Veszelka S, Nagy L,et al. Edaravone protects against methylglyoxal-induced barrier damage in human brain endothelial cells. PLoS One 2014; 9: e100152. doi: 10.1371/journal.pone.0100152 PMID: 25033388
35. Emery M, Schorderet DF, Roduit R. Acute hypoglycemia induces retinal cell death in mouse. PLoS One 2011; 6: e21586. doi: 10.1371/journal.pone.0021586 PMID: 21738719
36. Sahin K, Tuzcu M, Orhan C, Ali S, Sahin N, Gencoglu H, et al. Chromium modulates expressions of neuronal plasticity markers and glial fibrillary acidic proteins in hypoglycemia-induced brain injury. Life Sci. 2013; 93: 1039-1048. doi: 10.1016/j.lfs.2013.10.009 PMID: 24157456
37. Artus C, Glacial F, Ganeshamoorthy K, Ziegler N, Godet M, Guilbert T, et al. The Wnt/planar cell polarity signaling pathway contributes to the integrity of tight junctions in brain endothelial cells. J Cereb Blood Flow Metab. 2014; 34: 433-440. doi: 10.1038/jcbfm.2013.213 PMID: 24346691
38. Forster C, Burek M, Romero IA, Weksler B, Couraud PO, Drenckhahn D. Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier. J Physiol. 2008; 586: 1937-1949. doi: 10.1113/jphysiol.2007.146852 PMID: 18258663
39. Naik P, Fofaria N, Prasad S, Sajja RK, Weksler B, Couraud PO, et al. Oxidative and pro-inflammatory impact of regular and denicotinized cigarettes on blood brain barrier endothelial cells: is smoking reduced or nicotine-free products really safe? BMC Neurosci. 2014; 15: 51. doi: 10.1186/1471-2202-15-51 PMID: 24755281
40. Daniels BP, Cruz-Orengo L, Pasieka TJ, Couraud PO, Romero IA, Weksler B, et al. Immortalized human cerebral microvascular endothelial cells maintain the properties of primary cells in an in vitro model of immune migration across the blood brain barrier. J Neurosci Methods 2013; 212: 173-179. doi: 10.1016/j.jneumeth.2012.10.001 PMID: 23068604
41. Cucullo L, Couraud PO, Weksler B, Romero IA, Hossain M, Rapp E, et al. Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies. J Cereb Blood Flow Metab. 2008; 28: 312-328. PMID: 17609686
42. Nakayama K, Frew IJ, Hagensen M, Skals M, Habelhah H, Bhoumik A, et al. Siah2 regulates stability of prolyl-hydroxylases, controls HIF1alpha abundance, and modulates physiological responses to hypoxia. Cell. 2004; 117: 941-952. PMID: 15210114
43. Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol. 2003; 161: 653-660. PMID: 12743111
44. Soma T, Chiba H, Kato-Mori Y, Wada T, Yamashita T, Kojima T, et al. Thr(207) of claudin-5 is involved in size-selective loosening of the endothelial barrier by cyclic AMP. Exp Cell Res. 2004; 300: 202-212. PMID: 15383327
45. Coisne C, Engelhardt B. Tight junctions in brain barriers during central nervous system inflammation. Antioxid Redox Signal. 2011; 15: 1285-1303. doi: 10.1089/ars.2011.3929 PMID: 21338320
46. Freeman LR, Keller JN. Oxidative stress and cerebral endothelial cells: regulation of the blood-brain-barrier and antioxidant based interventions. Biochim Biophys Acta. 2012; 1822: 822-829. doi: 10.1016/j.bbadis.2011.12.009 PMID: 22206999
47. Hosoya T, Maruyama A, Kang MI, Kawatani Y, Shibata T, Uchida K, et al. Differential responses of the Nrf2-Keap1 system to laminar and oscillatory shear stresses in endothelial cells. J Biol Chem. 2005; 280: 27244-27250. PMID: 15917255
48. Taddei A, Giampietro C, Conti A, Orsenigo F, Breviario F, Pirazzoli V, et al. Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat Cell Biol. 2008; 10: 923-934. doi: 10.1038/ncb1752 PMID: 18604199
49. Pang H, Yi P, Wu P, Liu Z, Liu Z, Gong J, et al. Effect of lipoxin A4 on lipopolysaccharide-induced endothelial hyperpermeability. ScientificWorldJournal 2011; 11: 1056-1067. doi: 10.1100/tsw.2011.98 PMID: 21552771
50. Abdul Muneer PM, Alikunju S, Szlachetka AM, Murrin LC, Haorah J. Impairment of brain endothelial glucose transporter by methamphetamine causes blood-brain barrier dysfunction. Mol Neurodegener. 2011; 6: 23. doi: 10.1186/1750-1326-6-23 PMID: 21426580
51. Terashima J, HabanoW, Gamou T, Ozawa S. Induction of CYP1 family members under low-glucose conditions requires AhR expression and occurs through the nuclear translocation of AhR. Drug Metab Pharmacokinet. 2011; 26: 577-583. doi: 10.2133/dmpk.DMPK-11-RG-054 PMID: 21878739